URB597
URB597 (KDS-4103)是一种口服生物有效的FAAH抑制剂,IC50为4.6 nM,对其他大麻黄素相关靶点没有抑制活性。Phase 1。
-
货号:
TK0464 -
规格:
- 1mg
- 5mg
- 10mg
- 25mg
-
价格:
¥0.00
URB597 (KDS-4103)是一种口服生物有效的FAAH抑制剂,IC50为4.6 nM,对其他大麻黄素相关靶点没有抑制活性。Phase 1。
| CAS No. | 546141-08-6 |
| 生物活性 | URB-597 (KDS-4103) is an orally bioavailable and selective FAAH inhibitor. URB-597 inhibits FAAH activity with an IC50s of approximately 5 nM in rat brain membranes, 0.5 nM in intact rat neurons, 3 nM in human liver microsomes. Antidepressant-like effects. Analgesic activity. |
| 分子式 | C20H22N2O3 |
| 分子量 | 338.4 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存条件 | Powder, -20°C ,3 years |
| 溶解性数据 | DMSO : ≥ 100 mg/mL (295.51 mM),H2O : 0.1 mg/mL (0.30 mM; ultrasonic and warming and heat to 50°C) |
| 体内研究 | URB-597 (KDS-4103) inhibits rat brain FAAH activity after intraperitoneal (i.p.) administration with a median inhibitory dose (ID50) of 0.15 mg/kg in wild-type mice (+/+) or FAAH-null mice (-/-).KDS-4103 (0.1-0.3 mg/kg, i.p.) elicits significant, anxiolytic-like, antidepressant-like and analgesic effects, which are prevented by treatment with CB1 receptor antagonists in rats and mice.URB-597 inhibits FAAH in the brain rapidly (1 h), sustains at >90% through 12 h and >60% through 24 h after an oral dose of 10 mg/kg. |
| 体外研究 | URB-597 (KDS-4103) prevents the FAAH-catalyzed hydrolysis of [H]anandamide by primary cultures of rat cortical neurons with an IC50 value of ~0.50 nM. |
| 纯度及产品资料 | 98% |